actinium has been researched along with Glioblastoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almaguel, FG; Debinski, W; Herpai, DM; Mintz, A; Pandya, DN; Sattiraju, A; Solingapuram Sai, KK; Wadas, TJ; Xuan, A | 1 |
| Dorsey, JF; Jung, Y; Li, KC; Mintz, A; Pandya, DN; Sai, KKS; Sattiraju, A; Sun, Y; Wadas, TJ; Xiong, X; Xuan, A | 1 |
| Behling, K; Gutin, PH; López Puebla, JC; Maguire, WF; McDevitt, MR; O'Donoghue, J; Ruggiero, A; Scheinberg, DA; Sprinkle, SR | 1 |
3 other study(ies) available for actinium and Glioblastoma
| Article | Year |
|---|---|
IL13RA2 targeted alpha particle therapy against glioblastomas.
Topics: Actinium; Alpha Particles; Animals; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Copper Radioisotopes; Cysteamine; Disease Models, Animal; DNA Breaks, Double-Stranded; Gene Expression; Glioblastoma; Humans; Interleukin-13 Receptor alpha2 Subunit; Isotope Labeling; Male; Mice; Peptides; X-Ray Microtomography; Xenograft Model Antitumor Assays | 2017 |
Alpha Particle Enhanced Blood Brain/Tumor Barrier Permeabilization in Glioblastomas Using Integrin Alpha-v Beta-3-Targeted Liposomes.
Topics: Actinium; Alpha Particles; Animals; Biological Transport; Blood-Brain Barrier; Capillary Permeability; Cell Line, Tumor; DNA Damage; Drug Delivery Systems; Glioblastoma; Humans; Integrin alphaVbeta3; Liposomes; Mice; Neovascularization, Pathologic | 2017 |
Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma.
Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Blood Vessels; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Mice; Neoplasm Grading; Radiochemistry; Radioimmunotherapy; Radiotherapy Dosage | 2016 |